Results 151 to 160 of about 535,750 (289)
Validating novel tau positron emission tomography tracer [F‐18]‐AV‐1451 (T807) on postmortem brain tissue
Annals of Neurology, 2015 M. Marquié, M. Normandin, C. Vanderburg, Isabel Costantino, Elizabeth A Bien, Lisa G Rycyna, W. Klunk, C. Mathis, M. Ikonomovic, M. Debnath, N. Vasdev, B. Dickerson, S. Gomperts, J. Growdon, Keith A. Johnson, M. Frosch, B. Hyman, T. Gómez-Isla +17 moresemanticscholar +1 more source[18F]AV‐1451 tau positron emission tomography in progressive supranuclear palsy
Movement Disorders, 2017 J. Whitwell, V. Lowe, Nirubol Tosakulwong, S. Weigand, M. Senjem, C. Schwarz, Anthony J. Spychalla, R. Petersen, C. Jack, K. Josephs +9 moresemanticscholar +1 more sourceCannabinoid 1 receptor availability in posttraumatic stress disorder: A positron emission tomography study. [PDF]
Transl PsychiatryKorem N, Bassir Nia A, Hillmer AT, D'Souza D, Nabulsi N, Ropchan J, Huang Y, Cosgrove K, Levy I, Pietrzak RH, Harpaz-Rotem I. +10 moreeuropepmc +1 more sourceClinical impact of 68Ga‐prostate‐specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in patients with prostate cancer with rising prostate‐specific antigen after treatment with curative intent: preliminary analysis of a multidisciplinary approach
BJU International, 2017 S. Albisinni, C. Artigas, F. Aoun, I. Biaou, J. Grosman, T. Gil, E. Hawaux, K. Limani, F. Otte, A. Peltier, S. Sideris, N. Sirtaine, P. Flamen, R. Velthoven +13 moresemanticscholar +1 more source